amg pharmaceuticals limited Company Information
Company Number
11680825
Next Accounts
Dec 2024
Industry
Wholesale of pharmaceutical goods
Shareholders
ravinder bhandal
charnjit bhandal
Group Structure
View All
Contact
Registered Address
sterling house, 71 francis road, edgbaston,, birmingham, B16 8SP
Website
-amg pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMG PHARMACEUTICALS LIMITED at £2.7m based on a Turnover of £6.1m and 0.44x industry multiple (adjusted for size and gross margin).
amg pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMG PHARMACEUTICALS LIMITED at £2.3m based on an EBITDA of £532.7k and a 4.26x industry multiple (adjusted for size and gross margin).
amg pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMG PHARMACEUTICALS LIMITED at £1m based on Net Assets of £528.8k and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amg Pharmaceuticals Limited Overview
Amg Pharmaceuticals Limited is a live company located in birmingham, B16 8SP with a Companies House number of 11680825. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 2018, it's largest shareholder is ravinder bhandal with a 50% stake. Amg Pharmaceuticals Limited is a young, mid sized company, Pomanda has estimated its turnover at £6.1m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amg Pharmaceuticals Limited Health Check
Pomanda's financial health check has awarded Amg Pharmaceuticals Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
5 Weak
Size
annual sales of £6.1m, make it smaller than the average company (£25.7m)
- Amg Pharmaceuticals Limited
£25.7m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Amg Pharmaceuticals Limited
- - Industry AVG
Production
with a gross margin of 23.5%, this company has a comparable cost of product (23.5%)
- Amg Pharmaceuticals Limited
23.5% - Industry AVG
Profitability
an operating margin of 7.3% make it more profitable than the average company (3.6%)
- Amg Pharmaceuticals Limited
3.6% - Industry AVG
Employees
with 13 employees, this is below the industry average (38)
13 - Amg Pharmaceuticals Limited
38 - Industry AVG
Pay Structure
on an average salary of £66.4k, the company has an equivalent pay structure (£66.4k)
- Amg Pharmaceuticals Limited
£66.4k - Industry AVG
Efficiency
resulting in sales per employee of £469.6k, this is less efficient (£644.7k)
- Amg Pharmaceuticals Limited
£644.7k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is earlier than average (60 days)
- Amg Pharmaceuticals Limited
60 days - Industry AVG
Creditor Days
its suppliers are paid after 95 days, this is slower than average (34 days)
- Amg Pharmaceuticals Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 56 days, this is in line with average (58 days)
- Amg Pharmaceuticals Limited
58 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (9 weeks)
3 weeks - Amg Pharmaceuticals Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 80.7%, this is a higher level of debt than the average (56.8%)
80.7% - Amg Pharmaceuticals Limited
56.8% - Industry AVG
AMG PHARMACEUTICALS LIMITED financials
Amg Pharmaceuticals Limited's latest turnover from March 2023 is estimated at £6.1 million and the company has net assets of £528.8 thousand. According to their latest financial statements, Amg Pharmaceuticals Limited has 13 employees and maintains cash reserves of £153.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Nov 2019 | |
---|---|---|---|---|
Turnover | ||||
Other Income Or Grants | ||||
Cost Of Sales | ||||
Gross Profit | ||||
Admin Expenses | ||||
Operating Profit | ||||
Interest Payable | ||||
Interest Receivable | ||||
Pre-Tax Profit | ||||
Tax | ||||
Profit After Tax | ||||
Dividends Paid | ||||
Retained Profit | ||||
Employee Costs | ||||
Number Of Employees | 13 | 6 | ||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Nov 2019 | |
---|---|---|---|---|
Tangible Assets | 683,206 | 376,203 | 205,266 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 |
Investments & Other | 122,352 | 104,022 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
Total Fixed Assets | 805,558 | 480,225 | 205,266 | 0 |
Stock & work in progress | 726,446 | 192,531 | 0 | 0 |
Trade Debtors | 704,464 | 817,278 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 |
Misc Debtors | 347,432 | 170,875 | 20,438 | 0 |
Cash | 153,890 | 641,858 | 9,132 | 0 |
misc current assets | 0 | 0 | 0 | 0 |
total current assets | 1,932,232 | 1,822,542 | 29,570 | 0 |
total assets | 2,737,790 | 2,302,767 | 234,836 | 0 |
Bank overdraft | 0 | 0 | 4,667 | 0 |
Bank loan | 11,200 | 11,200 | 0 | 0 |
Trade Creditors | 1,227,252 | 779,109 | 1,631 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 |
hp & lease commitments | 43,239 | 15,681 | 9,021 | 0 |
other current liabilities | 755,216 | 1,249,334 | 187,267 | 0 |
total current liabilities | 2,036,907 | 2,055,324 | 202,586 | 0 |
loans | 22,311 | 32,133 | 45,333 | 0 |
hp & lease commitments | 149,774 | 57,734 | 39,107 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 |
total long term liabilities | 172,085 | 89,867 | 84,440 | 0 |
total liabilities | 2,208,992 | 2,145,191 | 287,026 | 0 |
net assets | 528,798 | 157,576 | -52,190 | 0 |
total shareholders funds | 528,798 | 157,576 | -52,190 | 0 |
Mar 2023 | Mar 2022 | Mar 2021 | Nov 2019 | |
---|---|---|---|---|
Operating Activities | ||||
Operating Profit | ||||
Depreciation | 87,365 | 43,266 | 5,165 | |
Amortisation | 0 | 0 | 0 | |
Tax | ||||
Stock | 533,915 | 192,531 | 0 | 0 |
Debtors | 63,743 | 967,715 | 20,438 | 0 |
Creditors | 448,143 | 777,478 | 1,631 | 0 |
Accruals and Deferred Income | -494,118 | 1,062,067 | 187,267 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||
Investing Activities | ||||
capital expenditure | ||||
Change in Investments | 18,330 | 104,022 | 0 | 0 |
cash flow from investments | ||||
Financing Activities | ||||
Bank loans | 0 | 11,200 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 |
Long term loans | -9,822 | -13,200 | 45,333 | 0 |
Hire Purchase and Lease Commitments | 119,598 | 25,287 | 48,128 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 |
share issue | ||||
interest | ||||
cash flow from financing | ||||
cash and cash equivalents | ||||
cash | -487,968 | 632,726 | 9,132 | 0 |
overdraft | 0 | -4,667 | 4,667 | 0 |
change in cash | -487,968 | 637,393 | 4,465 | 0 |
amg pharmaceuticals limited Credit Report and Business Information
Amg Pharmaceuticals Limited Competitor Analysis
Perform a competitor analysis for amg pharmaceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in B16 area or any other competitors across 12 key performance metrics.
amg pharmaceuticals limited Ownership
AMG PHARMACEUTICALS LIMITED group structure
Amg Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
AMG PHARMACEUTICALS LIMITED
11680825
amg pharmaceuticals limited directors
Amg Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Charnjit Bhandal (Nov 2018) and Mrs Ravinder Bhandal (Dec 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Charnjit Bhandal | 58 years | Nov 2018 | - | Director | |
Mrs Ravinder Bhandal | United Kingdom | 62 years | Dec 2019 | - | Director |
P&L
March 2023turnover
6.1m
+41%
operating profit
445.3k
0%
gross margin
23.6%
+3.24%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
528.8k
+2.36%
total assets
2.7m
+0.19%
cash
153.9k
-0.76%
net assets
Total assets minus all liabilities
amg pharmaceuticals limited company details
company number
11680825
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
November 2018
age
6
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
sterling house, 71 francis road, edgbaston,, birmingham, B16 8SP
Bank
-
Legal Advisor
-
amg pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to amg pharmaceuticals limited. Currently there are 1 open charges and 1 have been satisfied in the past.
amg pharmaceuticals limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AMG PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
amg pharmaceuticals limited Companies House Filings - See Documents
date | description | view/download |
---|